|
|
|
|
||
Re: New team up on blood cancersNot to get ahead of ourselves here but the initial deal between GILD and IMMU was a partnership for testing combos of Trodelvy; this ultimately turned into a buyout. I think if GILD are interested, they may negotiate harder for an IMGN acquisition as the IMMU purchase was rather widely panned as having been too rich... |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
54942 | Re: New team up on blood cancers | EFJ61 | 0 | 12/9/2022 10:07:31 AM |